Drug reference

sitagliptin

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Drug class

Endocrine (Peptide analogues)

Mechanism of action

Dipeptyl peptidase-IV (DPP-4) inhibitor; increases and prolongs incretin hormone activity, which is inactivated by DPP-4 enzyme, Incretins increase insulin release and synthesis from pancreatic beta cells and reduce glucagon secretion from pancreatic alpha cells

Common side effects

  • Upper respiratory tract infection
  • Nasopharyngitis
  • Constipation
  • Headache
  • Hypoglycemia

Known interactions (137)

Related conditions

Frequently asked questions

What drug class is sitagliptin?

sitagliptin belongs to: Endocrine.

How does sitagliptin work?

Dipeptyl peptidase-IV (DPP-4) inhibitor; increases and prolongs incretin hormone activity, which is inactivated by DPP-4 enzyme, Incretins increase insulin release and synthesis from pancreatic beta cells and reduce glucagon secretion from pancreatic alpha cells

What are the common side effects of sitagliptin?

Upper respiratory tract infection, Nasopharyngitis, Constipation, Headache, Hypoglycemia

Which drugs interact with sitagliptin?

albiglutide, amlodipine-benazepril, aripiprazole, asenapine, benazepril, bisoprolol, captopril, captopril-hydrochlorothiazide, chlorpropamide, chlorthalidone, clozapine, darunavir, dexamethasone, dulaglutide, exenatide

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug reference